Severity of chronic kidney disease did not influence bleeding during treatment of acute coronary syndromes.
We assessed the influence of CKD on bleeding in 200 patients with ACS via retrospective chart analysis. Using K/DOQI guidelines to stratify patients based on GFR, no differences in documented bleeding or antithrombotic utilization were observed among the groups. Due to increased mortality risk of patients with CKD from cardiovascular disease, assessing benefit-to-risk ratios of various medical interventions is crucial.
Lee
Andrew
A
University of Hawaii John A Burns School of Medicine, Honolulu, HI 96813-2427, USA.
Lum
Jeremy J
JJ
Seto
Todd B
TB
Spies
Christian
C
Madison
James R
JR
D000208:Acute Disease; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006254:Hawaii; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000145:classification / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008485:Medical Audit; D018570:Risk Assessment; D012720:Severity of Illness Index
D005343:Fibrinolytic Agents